Tequin

Lea en español

TequinTequin, one of the brand names for the pharmaceutical product Gatifloxacin, was introduced to the U.S. market by Bristol-Myers Squibb in 1999. The drug, an antibiotic, was prescribed primarily for the treatment of respiratory tract infections.

In 2006, a report in the New England Journal of Medicine alleged that Tequin had been found to put users at an elevated risk for dysglycemia, a blood sugar metabolism disorder that may manifest as either hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar). Initially, Bristol-Myers Squibb notified health care providers that product warnings would be enhanced. However, the company subsequently opted to terminate the manufacture of Tequin. The product is now available only as treatment for eye conditions, in the form of an eye drop.

If you experienced side effects after being prescribed Tequin, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Slip-and-fall Claims on Commercial Property

Your Best Chance of Recovery When You Are Hurt on Business Premises As a general rule, all property…

Read More 02 Dec 2019, Monday

Thanksgiving—A Time of Gratitude

Life is about connection… about the power of relationships to help us find and nurture our best se…

Read More 27 Nov 2019, Wednesday

Deficiency Judgment and Foreclosures

A person borrowing money to buy a home assumes the loan is secured by the mortgage lien on the house…

Read More 07 Nov 2019, Thursday